Melanoma Overdiagnosis: A Massive Problem

The presentation focuses on the significant issue of melanoma overdiagnosis, arguing that the increasing incidence of melanoma, which has risen six-fold over the past 40 years while mortality rates have remained stable, indicates a problem of overdiagnosis. Overdiagnosis refers to identifying a disease that would not have caused harm without intervention. A substantial portion of melanomas diagnosed are thin (under 1mm) and the increase in cases can be attributed largely to improved detection rather than an actual rise in harmful disease. The speaker highlights that screening efforts do not correlate with decreased mortality rates in both Germany and the United States, leading to heightened incidences of diagnosed melanomas without clinical relevance. Studies suggest that approximately 60% of detected melanomas may be overdiagnosed, with melanoma in situ possibly showing up to 90% overdiagnosis. The psychological ramifications of these diagnoses are discussed, emphasizing the anxiety and life disturbances faced by patients, who often experience fear of recurrence and guilt. The speaker argues that current practices in melanoma screening promote more harm than benefit and calls for a re-evaluation of these practices within the medical community to address potential negative outcomes of overdiagnosis.